AzurRx BioPharma Inc. | Mutual Funds
Mutual Funds that own AzurRx BioPharma Inc.
Vanguard Total Stock Market Index Fund
348,814
2.06%
0
0%
07/31/2018
Vanguard Extended Market Index Fund
40,665
0.24%
11,451
0%
07/31/2018
iShares Micro Cap ETF
27,226
0.16%
0
0.01%
09/06/2018
Vanguard Institutional Total Stock Market Index Fund
21,962
0.13%
0
0%
07/31/2018
Vanguard Total Stock Market Index Trust
4,762
0.03%
0
0%
07/31/2018
3,384
0.02%
0
0.03%
09/05/2018
AXA/Lord Abbett Micro Cap Portfolio
817
0.01%
0
0%
03/31/2018
Vanguard Balanced Index Fund
198
0%
0
0%
07/31/2018
| Address |
760 Parkside Avenue
Brooklyn New York 11226
United States
|
|
Employees
|
- |
| Website |
http://www.azurrx.com |
| Updated |
07/08/2019 |
| AzurRx BioPharma, Inc. is a development stage company, which engages in the research and development of non-systemic biologics for the treatment of patients with gastrointestinal disorders. It offers MS1819 and AZX1101 that are therapeutic proteins products under development. The company was founded on January 30, 2014 and is headquartered in Brooklyn, NY. |
